Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2149
Peer-review started: April 16, 2021
First decision: June 27, 2021
Revised: July 13, 2021
Accepted: September 19, 2021
Article in press: September 19, 2021
Published online: December 15, 2021
Processing time: 242 Days and 21 Hours
Hepatocellular carcinoma (HCC) surveillance rates reported from the United States and Europe remain low, despite published clinical guideline recommendations. Surveillance patterns in Australia, which has the benefit a universal healthcare program, have not been clearly delineated.
Patients, and evaluate factors associated with greater uptake of HCC cancer screening. In incorporating both frequency of screening and quantity of imaging performed, we aimed to have a more continuous way of standardising ‘adherence’. Identification of determinants associated with higher HCC screening adherence aims to guide further areas for intervention.
As stated above, the objectives were characterising continuous HCC surveillance adherence. This method provides a way of standardising ‘adherence’, and thus allows for equal comparison between different studies evaluating the concept of HCC screening adherence.
This was a retrospective cohort study that incorporated data electronic medical records to obtain patient demographics, clinical history, lab investigations and radiological imaging results. Data analysis was both on the univariate and multi
Follow-up of 775 at-risk patients demonstrated that median time-up-to-date with HCC surveillance was 84.2%. However, different patient factors, affected HCC surveillance adherence variably across different ranges of the outcome variable percentage of time up-to-date with HCC surveillance (PTUDS). At the 25th quantile/percentile for PTUDS, older age was associated with greater HCC surveillance. At the 50th quantile, African ethnicity had lower HCC surveillance. At the 75th quantile, cirrhotic status was associated with greater adherence to surveillance. Those of culturally and linguistically diverse backgrounds had lower continuous HCC surveillance rates at both the 50th and 75th quantiles. The ramifications of these findings and identified determinants affecting HCC surveillance participation in other settings, including the primary care setting, are less clear. However, they remain very important areas for further research. In particular, addressing the impact of ethnicity and cultural and linguistic backgrounds on screening uptake may well have beneficial consequent effects in other areas of healthcare.
The study suggests specific patient and systemic factors that contribute to partici
Future research should be directed at determining interventions aimed at the factors identified in this study to be associated with reduced HCC screening adherence. Those that improve participation in HCC surveillance may well benefit from widespread implementation to improve earlier diagnosis of HCCs.
